Celsis International introduces the next generation in bioluminescence technology that screens for microbial contamination of personal care products reportedly 25 to 50% faster than traditional ATP bioluminescence assays.
AKuScreen, according to the company, provides a cost saving method to reduce the testing and release times of raw materials through to finished goods, which the company believes further improves supply chain management and reducing working capital requirements.
